Xevant and Ivím Health Join Forces to Bring First Full Service Corporate GLP-1 Program, Ivím at Work, to Employees

LEHI, Utah–(BUSINESS WIRE)–Xevant, the leading provider of data analytics for healthcare solutions, and Ivím Health, the industry-leading provider of GLP-1 weight loss programs, today announced a strategic partnership between the two companies introducing the first corporate-designed medical weight loss solution, Ivím at Work with Xevant, to the market. Not only will this program offer medical weight loss as a corporate benefit, but it also sets a benchmark for exemplary clinical care and broadened access to GLP-1 medications. Setting a new gold standard for employer health benefit programs, Ivím at Work will significantly reduce employer healthcare costs while optimizing health outcomes for all participating employees through the most advanced clinical approach to obesity care and medical weight management.

Xevant Unveils 2023 Drug Trend Report: Insights into Key Drivers of Pharmaceutical Costs

LEHI, UT, UNITED STATES /EINPresswire.com/ — Xevant, a leading provider of pharmacy benefit management (PBM) analytics, has released its 2023 Drug Trend Report. The report offers detailed insights into key drivers of pharmaceutical cost changes between calendar year 2022 and 2023 and guides stakeholders navigating the evolving pharmacy landscape.

Xevant Unveils 2024 Drug Price Inflation White Paper: Real-Time Insight for Lower Costs and Improved Health Outcomes

LEHI, UT, UNITED STATES, February 28, 2024 /EINPresswire.com/ — Xevant, a leading provider of healthcare analytics and technology solutions, proudly announces the release of its latest white paper on 2024 Drug Price Inflation. This comprehensive report delves into the intricate landscape of pharmaceutical pricing, offering valuable insights into the impacts of the annual adjustments on drug costs and, consequently, healthcare expenditure.

Xevant Releases Key Platform Enhancements To Drive Down Drug Costs and Increase Access To Affordable Medication

LEHI, Utah, Nov. 28, 2023 (GLOBE NEWSWIRE) — Xevant, a leading provider of healthcare analytics and technology solutions, announced several key advancements to its PBM analytics platform making it easier to put data to work for the pharmacy benefits market, with the speed, scale, and user experience (UX) needed to drive down prescription drug costs and increase access to affordable medications.

Xevant’s Sahily Paoline Honored With Excellence Award in Product Development At the 2023 Globee Awards For Women in Business

LEHI, UT, November 16, 2023 ( ACCESSWIRE) In an industry where innovation and dedication set the foundation for impacting lives, Sahily Paoline, Chief Clinical Officer at Xevant, has emerged as a driving force. Her contributions, particularly in shining light on the clinical aspects of Xevant’s PBM analytics software, have now earned her the Woman Excellence of the Year Award in Product Development at the 16th Annual 2023 Globee® Awards for Women in Business.

The Future of Pharmacy Benefits: Xevant’s Latest eBook Unveils “The Top 4 PBM Trends (And What to Expect Next)”

LEHI, Utah, Oct. 16, 2023 (GLOBE NEWSWIRE) — Xevant, a leading healthcare analytics and technology solutions provider, is excited to announce the launch of its latest eBook, “The Top 4 PBM Trends (And What to Expect Next).” Rooted in its mission to achieve the lowest net healthcare cost through intelligent, real-time, automated technology, this comprehensive guide serves as a beacon for healthcare decision-makers, equipping them with essential knowledge to navigate the complexities of the evolving PBM landscape.

Xevant Recognized For Excellence and Thought Leadership

Lehi, Utah – October 2, 2023 – Xevant, a leading provider of healthcare analytics and technology solutions, had an impactful presence at the Pharmacy Benefit Management Institute’s (PBMI) Annual National Conference, held September 6-8, 2023 in Orlando.